This is a limited company view. Sign up for a Free Trial to see everything.

Stem CentRx develops therapies and diagnostics for cancer patients.

B2B
Biotechnology
Cleantech
Healthcare
Pharmaceuticals
Wind Power

Overview

Location

Bay Area

Founded

2008

Employees

176

Stage

Acquired

Total funding

$574M

Last funding

2 years ago

Acquisitions

0

Growth score

-35

Mindshare score

-125

Scoring

Deals

$250.0M Series G

Founders Fund, ARTIS Ventures

Sep 9, 2015

$100.0M Series F

Founders Fund, ARTIS Ventures

Jan 22, 2015

$200.0M Series E

Founders Fund, ARTIS Ventures, The Capital Group

May 30, 2014

$23.5M Venture

ARTIS Ventures

Mar 16, 2011

Employee Growth

Use StemCentRx's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use StemCentRx's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Senior Group Leader, Software Engineering
Manager, QC Bioassay
Senior Medical Director
Director, Legal
Senior Director of Intellectual Property
Office Manager
Senoir Director, Strategy and Business Development
Associate Director QA Validation
Associate Director of Protein Engineering
Director
Sr. Manager, Document Control
Drug Safety Manager
Associate Director, Molecular Biology
Senior Director & Head, Medical Affairs
Scientist II
Scientist
Associate Scientist II
Principal Scientist
Senior Clinical Pharmacokineticist I

Similar Companies

X4 Pharmaceuticals

X4 Pharmaceuticals is a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment of refractory solid tumors.
Series B|28 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes